Terms & Conditions / Privacy Policy
Innovative Research products should only be used in accordance with the following usage statement:
This material is sold for in-vitro use only in manufacturing and research. This material is not suitable for human use. It is the responsibility of the user to undertake sufficient verification and testing to determine the suitability of each product's application. The statements herein are offered for informational purposes only and are intended to be used solely for your consideration, investigation and verification.
This statement is derived from the following FDA Guidance Document, issued on November 25th, 2013: Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only
Privacy Notice
This privacy notice discloses the privacy practices for www.innov-research.com. This privacy notice applies solely to information collected by this website.
Information Collection, Use, and Sharing
We are the sole owners of the information collected on this site. We only have access to/collect information that you voluntarily give us via email or other direct contact from you. We will not sell or rent this information to anyone.
We will use your information to respond to you, regarding the reason you contacted us. We will not share your information with any third party outside of our organization, other than as necessary to fulfill your request, e.g. to ship an order.
Unless you ask us not to, we may contact you via email in the future to tell you about specials, new products or services, or changes to this privacy policy.
Your Access to and Control Over Information
You may opt out of any future direct contact from us at any time. You can do the following by contacting us via the email address or phone number given on our website:
- Change/correct any data we have about you.
- Have us delete any data we have about you.
- Express any concern you have about our use of your data.
Security
Wherever we collect sensitive information (such as credit card data), that information is encrypted and transmitted to us in a secure way. You can verify this by looking for a lock icon in the address bar and looking for "https" at the beginning of the address of the Web page.
While we use encryption to protect sensitive information transmitted online, we also protect your information offline. Only employees who need the information to perform a specific job (for example, billing or customer service) are granted access to personally identifiable information. The computers/servers in which we store personally identifiable information are kept in a secure environment.
Online Advertising & Remarketing
We do use third- party tracking cookies, including the Google AdWords tracking cookie. This means we might show ads to you across the internet, specifically on the Google Content Network (GCN). As always, we respect your privacy and are not collecting any identifiable information through the use of a remarketing system.
You can opt out of Google's use of cookies by visiting Google's Ads Settings. Alternatively, you can opt out of a third-party vendor's use of cookies by visiting the Network Advertising Initiative's opt-out page.
If you feel that we are not abiding by this privacy policy, you should contact us immediately via telephone at 248-896-0145 or via email at sales@innov-research.com.
Your source for all things biotech
Stay informed with our expert insights, industry news, and groundbreaking discoveries.
Targeting VEGF could do more harm than good in the eye
Preclinical studies have raised a potential red flag on anti-VEGF therapies, suggesting that increasingly aggressive use in eye disease could trip...
New References Published
Innovative Research has had several new references in publications over the past week. Below are just a few of the...
Fate's tissue regeneration proteins validated in vivo
San Diego-based Fate Therapeutics, which focuses on the discovery and development of adult stem cell modulators, has announced that its...
Kancera credits new drug with slowing pancreatic cancer tumor growth
From the FierceBiotech Article: Swedish drug developer Kancera says it has slowed the growth of pancreatic cancer tumors in preclinical...
Amgen enzyme combats obesity, diabetes in monkeys
Amgen (AMGN) has an interesting new weapon in the battle againstobesity. The company's scientists successfully used an antibody they discovered...